Evaluation of Preoperative Computed Tomography in Estimating Peritoneal Cancer Index in Colorectal Peritoneal Carcinomatosis

被引:0
作者
Ju-Li Koh
Tristan D. Yan
Derek Glenn
David L. Morris
机构
[1] University of New South Wales,Department of Surgery, St. George Hospital
[2] University of New South Wales,Department of Radiology, St. George Hospital
来源
Annals of Surgical Oncology | 2009年 / 16卷
关键词
Peritoneal Carcinomatosis; Preoperative Compute Tomography; Peritoneal Cancer Index; Complete Cytoreduction; Peritoneal Disease;
D O I
暂无
中图分类号
学科分类号
摘要
Peritoneal Cancer Index (PCI) has been recognized as an independent prognostic indicator for long-term outcomes. It also influences the likelihood of complete cytoreduction, another principal determinant of long-term survival. The objective of this study was to evaluate the utility of preoperative CT in estimating PCI during the patient selection process. The efficacy of CT in demonstrating peritoneal disease was evaluated by comparing the radiological and intraoperative lesion size and PCI scores using the Wilcoxon signed-rank test. Tumor distribution was assessed in each abdominopelvic region as tumor present versus absent. The sensitivity, specificity, positive predictive value, and negative predictive value were calculated in each abdominopelvic region. Overall, where CT identifies the presence of disease, it portrayed lesion size accurately in 60%, underestimated in 33%, and overestimated in 7% of cases. Analysis of individual abdominopelvic regions demonstrated a statistically significant difference between radiologically and intraoperatively visualized lesion sizes (P < 0.05) except in the epigastrium, left upper, and left flank regions. The sensitivity of CT in detecting peritoneal implants was influenced by lesion size. Small nodules (<0.5 cm) were visualized on CT with only a sensitivity of 11%, which is in contrast to 94% with nodules exceeding 5 cm. Radiological PCI scores significantly underestimated intraoperative PCI (P < 0.001). This study demonstrated that the sensitivity of CT in detecting peritoneal implants was influenced by lesion size and CT PCI significantly underestimated clinical PCI. The role of CT in refining patient selection and improving prognosis remains to be closely evaluated.
引用
收藏
页码:327 / 333
页数:6
相关论文
共 127 条
[1]  
Chu DZJ(1989)Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors Cancer. 63 364-7
[2]  
Lang NP(2002)Peritoneal carcinomatosis from colorectal cancer Br J Surg. 89 1545-50
[3]  
Thompson C(2000)Peritoneal carcinomatosis from non-gynecologic malignancies. Results of EVOCAPE 1 multicentric prospective study Cancer. 88 358-63
[4]  
Osteen PK(2003)Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer J Clin Oncol. 21 3737-43
[5]  
Westbrook KC(2004)Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J Clin Oncol. 22 3284-92
[6]  
Jayne DG(2001)Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin Eur J Cancer. 37 979-84
[7]  
Fook S(2004)Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma Ann Surg Oncol. 11 278-86
[8]  
Loi C(2006)Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion. Analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique Cancer. 106 1144-53
[9]  
Seow-Choen F(2007)Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: a prospective study of 70 consecutive cases Ann Surg Oncol. 14 515-25
[10]  
Sadeghi B(2007)Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy: a journey to becoming a nationally funded peritonectomy center Ann Surg Oncol. 14 2270-80